Targeting chaperone modifications: Innovative approaches to cancer treatment

Mariah Stewart1, Jonathan C Schisler2

  • 1The McAllister Heart Institute and Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

PubMed

Insights

Altered protein quality control, involving heat shock proteins (HSPs), impacts chronic diseases like cancer. Understanding HSP regulation and co-chaperone shifts offers new therapeutic targets for disease.

Area of Science:

  • Cellular Biology
  • Molecular Medicine
  • Biochemistry

Background:

  • Protein quality control systems are crucial for cellular function and are often dysregulated in diseases like cancer.
  • Heat shock proteins (HSPs) are key regulators within this system, influencing protein fate and cellular processes.
  • Understanding HSPs and their cofactors is vital for comprehending healthy and diseased cellular states.

Purpose of the Study:

  • To synthesize recent advancements in the protein quality control system, focusing on heat shock proteins.
  • To elucidate the regulatory mechanisms of HSPs and their cofactors in health and disease.
  • To explore how post-translational modifications govern protein interactions and cellular proliferation.

Main Methods:

  • Review of current literature on heat shock response and protein quality control.
  • Analysis of interactions between HSPs (HSP70, HSP90) and co-chaperones (CHIP, HOP).
  • Examination of post-translational modifications influencing the protein quality control network.

Main Results:

  • Identified a mechanistic shift in co-chaperone engagement (HOP to CHIP) with HSP70 and HSP90.
  • Demonstrated how this shift influences cellular growth and survival pathways.
  • Highlighted the role of post-translational modifications in regulating activation factors, chaperones, and co-chaperones.

Conclusions:

  • Dysregulation of the protein quality control system, particularly HSPs, is implicated in cancer.
  • The shift in co-chaperone engagement represents a critical regulatory event affecting cell proliferation.
  • Targeting the heat shock response system holistically may offer novel therapeutic strategies for cancer and other diseases.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K